Screening of single cell clones of the stable packaging cell lines identifies clones with superior productivity compared to the transient approach. Full process development is currently ongoing.


To address the production gap in AAV-based gene therapies, we have developed a stable, helper-virus free AAV production system.

Off-the shelf packaging cell lines are available and we are offering cell line development service for producer cell lines or custom-made packaging cell lines.